IONS | Ionis PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$40.42
-$0.82 (-1.99%)

Ionis Pharmaceuticals (IONS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $40.42 vs 50 $48.22 / 200 $66.43
Projection
No cross projected
Test
No active test
Last cross
Death cross 17 Jun 2026 ยท projected 9 bars out ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
below both $43.52 vs 50 $68.72 / 200 $49.06
Projection
Death cross estimated 15+ weeks out
Test
No active test
Last cross
Golden cross week of 3 Nov 2025 ยท projected 13 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $40.42 vs 50 $43.67 / 200 $56.02
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Jul 2026 ยท projected 8 bars out

Cross history

27
crosses on record since 2018
13 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Jul 2026Death4-hour8 bars outNot tested
6 Jul 2026Golden4-hour15 bars outNot tested
17 Jun 2026Death flatdaily9 bars out3 bar cross test
19 Mar 2026Death4-hour29 bars outNot tested
week of 3 Nov 2025Golden steepweekly13 bars outNot tested

About IONS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$132M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.